Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

VXA G2.4 NS

Next Previous
Drug Profile

VXA G2.4 NS

Alternative Names: GII.4 oral vaccine tablet - Vaxart; Monovalent GII.4 tableted vaccine - Vaxart; Norovirus GII.4 vaccine - Vaxart; VXA-G2-4-NS; VXA-G2.4-NS

Latest Information Update: 04 Aug 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vaxart
  • Class DNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Norovirus infections

Most Recent Events

  • 14 Apr 2026 Vaxart completes a phase I trial in Norovirus infections (Prevention, Combination therapy) in USA (PO) (NCT06944717)
  • 03 Mar 2026 Phase-I clinical trials in Norovirus infections (Prevention, Combination therapy) in USA (PO) (NCT06944717)
  • 19 Nov 2024 Phase-I development in Norovirus-infections (Prevention) is ongoing in USA (PO, Tablet)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top